国药雅德投资(香港)有限公司

About

Sinopharm International Investment Co., Ltd (“SIIC”), based on Hong Kong, is the Manager of the Fund. It has a Cayman and WOFE(Chinese) subsidiary.Sinopharm Group, the largest pharmaceutical group in China, and A large Chinese insurance group, are co-founders and have significant equity stak

Investment

Focus

China’s healthcare industry is the world’s largest and fastest-growing marketplace.China has been and will be the economic growth engine in the world.China's current healthcare expenditure is less than 6% of GDP, almost 1/3 of that of US, with huge potential to grow.Sinopharm Group is th

MORE+

Partners

The Best Partner

Sinopharm Group, the largest pharmaceutical group in China, and A large Chinese insurance group, are co-founders and have significant equity stakes in SIIC.

MORE +

Team

P R E V N E X T

HongGuo DE···

1992~2003, Dire···...

Edward WEN···

Senior investme···...

Dan LUO, P···

EMBA degree fro···...

Harris CHE···

Wall Street inv···...

News

P R E V N E X T

Over 4 million COVID-19 vaccine doses from China's CNBG administered in emergency use

More than 4 million COVID-19 vaccine doses from China National Biotec Group (CNBG) have been administered as of Jan. 4 via China’s emergency use program, the company’s parent firm said late on Thursday....

2020-12-18 14:33:21

MORE +

Turkey approves China-based Sinovac vaccine’s emergency use

Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China's Sinovac Biotech Ltd....

2020-12-18 14:33:21

MORE +

China to provide Afghanistan with 400,000 doses of COVID-19 vaccine

China has pledged to deliver 400,000 doses of Sinopharm’s COVID-19 vaccine to Afghanistan, Afghan officials said on Monday, in a boost for an immunisation campaign begun last week....

2020-12-18 14:33:21

MORE +